首页> 外国专利> 5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method

5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method

机译:5-羟基-1H-咪唑-4-羧酰胺有效剂量/敏感性预测方法和预测装置,黄嘌呤单磷酸的量测量方法,骨髓增生异常综合症治疗剂和治疗方法

摘要

#$%^&*AU2018202975A120180517.pdf#####ABSTRACT An object of the present invention is to provide a method and apparatus for predicting an effective dose of or the sensitivity to 5-hydroxy-1H-imidazole-4-carboxamide, which are capable of performing a determination in a simple operation and a short time, a method for determining amounts of xanthosine monophosphate, and a treatment agent and treatment method for treating myelodysplastic syndrome. According to the present invention, provided are a method for predicting an effective dose of or the sensitivity to 5-hydroxy-11-imidazole-4-carboxamide, including determining amounts of xanthosine monophosphate in blood and a prediction apparatus, a method for determining amounts of xanthosine monophosphate, including determining xanthosine monophosphate in blood in two different determining conditions by mass spectrometry, and a treatment agent and treatment method for treating myelodysplastic syndrome.
机译:#$%^&* AU2018202975A120180517.pdf #####抽象本发明的目的是提供一种用于预测的方法和设备5-羟基-1H-咪唑-4-羧酰胺的有效剂量或敏感性能够以简单的操作和短时间进行确定的方法确定黄嘌呤单磷酸的量,治疗剂和治疗方法治疗骨髓增生异常综合症的方法。根据本发明,提供了是一种预测的有效剂量或对的敏感性的方法5-羟基-11-咪唑-4-羧酰胺,包括确定黄嘌呤的量血液中的单磷酸盐和预测装置,确定血红蛋白含量的方法黄嘌呤单磷酸,包括在两次血液中测定黄嘌呤单磷酸质谱测定不同的确定条件,处理剂和处理方法治疗骨髓增生异常综合症的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号